Vancouver-based Sonus Microsystems has entered into a strategic partnership with Providence Health Care Ventures (PHCV), marking the first collaboration under PHCV’s newly launched Innovation Program. The partnership will accelerate the development and validation of Sonus’ cutting-edge wearable ultrasound patch for cardiac monitoring.
The partnership will connect Sonus’ groundbreaking technology with PHCV’s clinical network, allowing the company to test and refine its product in active healthcare environments.
“We are excited to partner with PHCV to advance our vision of transforming cardiac care,” said Hani Eskandari, CEO of Sonus Microsystems. “Leveraging PHCV’s extensive network of health care sites and clinical expertise will allow us to validate our product in real-world clinical settings, ultimately improving patient outcomes and enhancing healthcare delivery.”
At the heart of Sonus’ innovation is its proprietary Sonus Array Technology™, a polymer-based MEMS transducer system designed to deliver high-resolution, AI-driven imaging. The company’s wearable patch aims to bring hospital-grade echocardiography to the home, empowering clinicians with real-time data to better manage chronic heart conditions remotely.
Heart failure affects an estimated 750,000 Canadians and accounts for more hospital readmissions than any other condition. With 100,000 new cases diagnosed each year, the burden on the healthcare system continues to grow.
“Partnering with Sonus aligns with our commitment to advancing innovative healthcare solutions, particularly those related to remote patient monitoring, screening, and wearable ultrasound devices,” said Brian Simmers, President of PHCV. “We’re excited to explore how this technology could impact chronic disease management by integrating it into our clinical ecosystem.”
Clinicians at St. Paul’s Hospital—part of the Providence network—will be closely involved in the technology’s validation.
“The Sonus Patch has the potential to transform how we monitor and screen cardiac patients,” said Dr. Nathaniel Hawkins, a cardiologist and Physician Lead for the Regional Heart Failure Program. “Echocardiography is fundamental to diagnosing and managing heart disease, and bringing this capability to patients remotely could enable earlier detection, timely interventions, and improved long-term outcomes.”
Sonus Microsystems, founded in Vancouver, is pioneering new applications of ultrasound in remote care. Through its wearable patch, the company aims to offer accessible, high-performance cardiac diagnostics that reduce costs and improve patient care worldwide.
Leave a Reply